Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock Movers

On this episode of Stock Movers: - Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The company pledged to launch more…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.